These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 21448106
1. Hyperprolactinaemia with amisulpride. Ružić K, Grahovac T, Graovac M, Dadić-Hero E, Sepić-Grahovac D, Sabljić V. Psychiatr Danub; 2011 Mar; 23(1):92-4. PubMed ID: 21448106 [Abstract] [Full Text] [Related]
2. Normalization of hyperprolactinaemia after withdrawal of a low dose of amisulpride. Kopecek M, Bares M, Horácek J. Neuro Endocrinol Lett; 2005 Aug; 26(4):320. PubMed ID: 16136015 [No Abstract] [Full Text] [Related]
3. Hyperprolactinemia after low dose of amisulpride. Kopecek M, Bares M, Svarc J, Dockery C, Horácek J. Neuro Endocrinol Lett; 2004 Dec; 25(6):419-22. PubMed ID: 15665803 [Abstract] [Full Text] [Related]
4. Amisulpride-induced hyperprolactinemia is reversible following discontinuation. Paparrigopoulos T, Liappas J, Tzavellas E, Mourikis I, Soldatos C. Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan 30; 31(1):92-6. PubMed ID: 16938372 [Abstract] [Full Text] [Related]
9. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders. Lee JH, Dunner DL. Depress Anxiety; 2008 Jan 30; 25(2):91-7. PubMed ID: 17311265 [Abstract] [Full Text] [Related]
10. Antidepressants and psychosis in Parkinson disease: a case series. Voon V, Fox S, Butler TR, Lang AE. Int J Geriatr Psychiatry; 2007 Jun 30; 22(6):601-4. PubMed ID: 17450623 [No Abstract] [Full Text] [Related]
11. Combination therapy with amisulpride and antidepressants: clinical observations in case series of elderly patients with psychotic depression. Politis AM, Papadimitriou GN, Theleritis CG, Psarros C, Soldatos CR. Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul 01; 32(5):1227-30. PubMed ID: 18442877 [Abstract] [Full Text] [Related]
12. Hyperprolactinemia and possibly related development of prolactinoma during amisulpride treatment; three cases. Akkaya C, Kaya B, Kotan Z, Sarandol A, Ersoy C, Kirli S. J Psychopharmacol; 2009 Aug 01; 23(6):723-6. PubMed ID: 18562408 [Abstract] [Full Text] [Related]
13. [Pharmacotherapy of anxiety disorders]. Philipp M. Z Arztl Fortbild (Jena); 1995 May 01; 89(2):147-50. PubMed ID: 7610681 [Abstract] [Full Text] [Related]
14. Detection and treatment of depressive and anxiety disorders among cancer patients: feasibility and preliminary findings from a liaison service in an oncology division. Pasquini M, Biondi M, Costantini A, Cairoli F, Ferrarese G, Picardi A, Sternberg C. Depress Anxiety; 2006 May 01; 23(7):441-8. PubMed ID: 16841345 [Abstract] [Full Text] [Related]
15. [Drug treatment of anxiety disorders]. Scholz H, Lhotka R. Wien Med Wochenschr; 1991 May 01; 141(22):526-30. PubMed ID: 1686949 [Abstract] [Full Text] [Related]
16. Anxiety, depression, and psychosis in Parkinson's disease: unmet needs and treatment challenges. Chen JJ. Neurol Clin; 2004 Oct 01; 22(3 Suppl):S63-90. PubMed ID: 15501367 [No Abstract] [Full Text] [Related]
17. Lactation associated with fluoxetine treatment. Arya DK, Taylor WS. Aust N Z J Psychiatry; 1995 Dec 01; 29(4):697. PubMed ID: 8825840 [No Abstract] [Full Text] [Related]
18. Low-dose risperidone augmentation of antidepressants or anxiolytics is associated with hyperprolactinemia. Kopecek M, Bares M, Horacek J, Mohr P. Neuro Endocrinol Lett; 2006 Dec 01; 27(6):803-6. PubMed ID: 17187006 [Abstract] [Full Text] [Related]
19. Cabergoline-induced psychotic exacerbation in schizophrenic patients. Chang SC, Chen CH, Lu ML. Gen Hosp Psychiatry; 2008 Dec 01; 30(4):378-80. PubMed ID: 18585544 [Abstract] [Full Text] [Related]
20. Weight gain in a patient with schizophrenia switched from quetiapine to amisulpride. Chen YY, Huang MC, Wu KC. Psychiatry Clin Neurosci; 2008 Oct 01; 62(5):620-1. PubMed ID: 18950385 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]